<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ojneph
   </journal-id>
   <journal-title-group>
    <journal-title>
     Open Journal of Nephrology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2164-2842
   </issn>
   <issn publication-format="print">
    2164-2869
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ojneph.2025.152018
   </article-id>
   <article-id pub-id-type="publisher-id">
    ojneph-142718
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Severe IgA Vasculitis Nephritis in a 12-Year-Old Senegalese Child
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Pascale Ndongo
      </surname>
      <given-names>
       Njock
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Younoussa
      </surname>
      <given-names>
       Keita
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Aliou Abdoulaye
      </surname>
      <given-names>
       Ndongo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mame Diarra
      </surname>
      <given-names>
       Seye
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Anne Alvine Nloga
      </surname>
      <given-names>
       Ndjebayi
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Niang Mame
      </surname>
      <given-names>
       Fama
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Astrid Maelle
      </surname>
      <given-names>
       Awouamou
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Djibril
      </surname>
      <given-names>
       Boiro
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Cherif Mouhamed
      </surname>
      <given-names>
       Dial
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Gueye
      </surname>
      <given-names>
       Modou
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Sylla
      </surname>
      <given-names>
       Assane
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aPediatric Nephrology Department of Abass Ndao Hospital, Dakar, Senegal
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aPediatric Department of Abass Ndao Hospital, Dakar, Senegal
    </addr-line> 
   </aff> 
   <aff id="aff3">
    <addr-line>
     aPathology Department of Cheikh Anta Diop University, Dakar, Senegal
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     15
    </day> 
    <month>
     04
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    02
   </issue>
   <fpage>
    180
   </fpage>
   <lpage>
    189
   </lpage>
   <history>
    <date date-type="received">
     <day>
      9,
     </day>
     <month>
      January
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      19,
     </day>
     <month>
      January
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      19,
     </day>
     <month>
      May
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    IgA vasculitis is the most common childhood vasculitis. Rare among African descendants, renal manifestations remain poorly documented in children in Senegal. We report the case of a 12-year-old Senegalese adolescent who presented with a 3-week history of persistent acute nephritic syndrome associated with symmetrical purpura of lower limbs, polyarthralgia and abdominal pain. Laboratory tests revealed glomerular proteinuria associated with acute renal failure KDIGO Stage 3. Renal biopsy revealed immune deposits of IgA and C3, as well as 95% crescentic fibrocellular glomerulonephritis. The patient was treated with intravenous pulses of methylprednisolone, oral prednisolone and Azathioprine. The outcome was favorable, and the glomerular filtration rate was fully restored after three months of treatment. IgA vasculitis nephritis can be severe and affect vital prognosis and renal function. In our case, early diagnosis and prompt appropriate treatment restored kidney function and that of other affected organs.
   </abstract>
   <kwd-group> 
    <kwd>
     Acute Renal Failure
    </kwd> 
    <kwd>
      Children
    </kwd> 
    <kwd>
      Hematuria
    </kwd> 
    <kwd>
      IgA Vasculitis
    </kwd> 
    <kwd>
      Glomerulonephritis
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Background</title>
   <p>Henoch-Schönlein purpura or IgA vasculitis (IgAV) is a leukocytoclastic vasculitis of small vessels <xref ref-type="bibr" rid="scirp.142718-1">
     [1]
    </xref>. It is caused by acute perivascular deposition of immunoglobulin A (IgA) and sometimes is associated with C3, IgG, IgM, fibrin and properdin deposition in the capillaries wall of the dermis, glomeruli and the mesangium <xref ref-type="bibr" rid="scirp.142718-1">
     [1]
    </xref> <xref ref-type="bibr" rid="scirp.142718-2">
     [2]
    </xref>.</p>
   <p>About 90% of IgA vasculitis cases occur between the ages of 3 and 15 years old with a peak incidence at 6 years old <xref ref-type="bibr" rid="scirp.142718-2">
     [2]
    </xref>. Worldwide, Afro-Caribbeans and African Americans have the lowest incidence, while Asians and Caucasians have the highest incidence <xref ref-type="bibr" rid="scirp.142718-3">
     [3]
    </xref>. Positive clinical diagnosis is based on the European League Against Rheumatism (EULAR) clinical criteria associating a clinical tetrad of a palpable non-thrombocytopenic purpura, typically non-migratory and nondestructive polyarthralgias, gastrointestinal involvement and renal dysfunction <xref ref-type="bibr" rid="scirp.142718-4">
     [4]
    </xref> <xref ref-type="bibr" rid="scirp.142718-5">
     [5]
    </xref>. Renal manifestations of IgA vasculitis occur in 30% to 50% of cases. Most of the time, they are self-limiting. However, if they persist and remain undiagnosed, they can progress to chronic or end stage renal disease <xref ref-type="bibr" rid="scirp.142718-6">
     [6]
    </xref>. In Africa and Senegal in particular, the epidemiological description and diagnosis of IgA vasculitis nephritis remain a huge challenge, mainly due to late diagnosis and paucity of data.</p>
   <p>We report a case of IgA vasculitis nephritis (IgAVN) complicated by KDIGO stage 3 acute renal failure (ARF) in a 12-year-old Senegalese adolescent.</p>
  </sec><sec id="s2">
   <title>2. Case Report</title>
   <p>We report the case of a 12-year-old adolescent who consulted our pediatric nephrology department with a 3-week history of generalised skin rash, diffuse abdominal pain, polyarthralgia, facial and lower limbs swellings as well as dark brown urine.</p>
   <p>The history started with a sore throat followed by a pruritic papular eruption distributed over the upper limbs, then extending to the trunk, abdomen and both lower limbs. He first sought consultation at a primary health care facility, where an upper respiratory tract infection and urticaria were diagnosed. He received symptomatic treatment without clinical improvement after five days of treatment. This was followed by the onset of generalised and progressive colicky abdominal pain, throbbing polyarthralgia mainly in the knees and ankles, progressive swelling of the feet, early morning facial puffiness, intermittent high grade fever, anorexia and fatigue. All these elements motivated him to consult our pediatric nephrology department, where he was finally admitted.</p>
   <p>His past medical history was relevant for 3 episodes per year of recurrent pharyngitis. He reported family history of rheumatoid arthritis. Physical examination revealed a conscious patient, low-grade fever (T 38˚C), tachycardia (HR 130 b/min), normal respiratory rate (RR 20 C/min), stage 2 hypertension (BP 140/100 mmHg), normal blood glucose (1.09 g/dL). His urine was dark brown in color. Urinary output was 1.98 mL/kg/hr. His height and weight were 140 cm and 28 kg, respectively, giving a BMI for age of 14.28 (between -2 and -3 WHO Z score). The adolescent presented with periorbital edema, mild pitting edema of the dorsum of the feet and symmetrical hyper pigmented macular rashes on lower limbs and trunk (<xref ref-type="fig" rid="fig1">
     Figure 1
    </xref>). Abdominal examination revealed diffuse tenderness with no evidence of peritoneal irritation or organomegaly. The rest of physical examination was normal particularly at the level of the joints.</p>
   <fig id="fig1" position="float">
    <label>Figure 1</label>
    <caption>
     <title>Figure 1. Skin rashes on admission. (a) Hyper pigmented macular rashes on the thorax abdomen and upper limbs; (b) Symmetrical hyper pigmented macular rashes on both thighs.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2070660-rId14.jpeg?20250522021037" />
   </fig>
   <p>The urine dipstick showed 2++ proteinuria and 2++ hematuria. Laboratory tests revealed a urine Protein/Creatinine ratio (PCR) at 200 mg/mmol. Serum creatinine level was 19 mg/L. The estimated glomerular filtration rate (eGFR) was 30 mL/min/1.73m<sup>2</sup> (Schwartz). Anti-streptolysin O antibodies (ASLO) were negative. Serum C3 was normal. Other laboratory investigations are reported in <xref ref-type="table" rid="table1">
     Table 1
    </xref>. Abdominal ultrasound was normal. Esophagogastroduodenoscopy reported congestive pangastritis without ulcer. The chest X-ray was normal as well as the electrocardiogram result. The renal biopsy result showed crescentic fibrocellular glomerulonephritis involving 95% of the glomeruli, corresponding to IgAVN grade V of the International Study of Kidney Disease in Children (ISKDC) classification (<xref ref-type="fig" rid="fig2">
     Figure 2
    </xref>). IgA deposits were also found on immunohistochemistry, as shown in <xref ref-type="fig" rid="fig3">
     Figure 3
    </xref>.</p>
   <p>Based on the clinical picture, laboratory results, IgA deposits and crescentic fibrocellular glomerulonephritis on renal biopsy, the diagnosis of IgA vasculitis nephritis associated with acute renal failure KDIGO stage 3 was established as per EULAR classification criteria.</p>
   <table-wrap id="table1">
    <label>
     <xref ref-type="table" rid="table1">
      Table 1
     </xref></label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.142718-"></xref>Table 1. Laboratory results at admission.</title>
    </caption>
    <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
     <tr> 
      <td class="custom-bottom-td acenter" width="50.00%"><p style="text-align:center">Laboratory Tests</p></td> 
      <td class="custom-bottom-td acenter" width="50.00%"><p style="text-align:center">Admission results</p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="50.00%"><p style="text-align:center">Full blood count:</p></td> 
      <td class="custom-top-td acenter" width="50.00%"><p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">GB (10<sup>3</sup>/uL)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">26.37</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">NEUT (10<sup>3</sup>/uL)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">2.221</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">PLT (10<sup>3</sup>/uL)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">167</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">HB (g/dL)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">8.4</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">MCV (fL)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">80.6</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">MCHC (pg)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">34.6</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">CRP (mg/L)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">189.3</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Malaria Rapid Diagnostic test</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Negative</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Blood culture</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Negative</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">ASLO</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Negative</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Hepatitis BsAg</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Negative</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Anti Hbc antibodies</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Negative</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">HIV test</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Negative</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Serum C3 g/L</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">1.51</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Serum C4 g/L</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">0.21</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Serum CH50 U/mL</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">60</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Anti-native DNA</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Negative</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Total protein g/L</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">54.4</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Blood electrolytes</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Na+ (meq/L)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">127</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">K+ (meq/L)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">3.6</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Cl− (meq/L)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">114</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Phosphorus (mg/L)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">69.9</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Magnesium (mg/L)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">19.9</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Calcium (mg/L)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">93.5</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Blood group</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">O+</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">HB electrophoresis</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">AA</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Coagulation profile:</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Prothrombin time</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">100</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">INR</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">1.37</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">aPTT</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">31s</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Renal</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Urine dipstick</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Protein ++</p><p style="text-align:center">Haematuria ++</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Urine protein/creatinine ratio mg/mmol</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">200</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Creatinine mg/L</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">19</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">Urea g/L</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">1.12</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="50.00%"><p style="text-align:center">eGFR (Schwartz)</p></td> 
      <td class="acenter" width="50.00%"><p style="text-align:center">30.4 ml/min/1.73</p></td> 
     </tr> 
    </table>
   </table-wrap>
   <fig id="fig2" position="float">
    <label>Figure 2</label>
    <caption>
     <title>Figure 2. Crescentic glomerulonephritis. (a) Extracapillary fibrocellular proliferation around the flocculus. Masson trichrome Gx250; (b) Extracapillary proliferation and fibrosis of the flocculus. Masson trichrome Gx250; (c) Segmental cellular crescent. Masson trichrome Gx250; (d) Fibrocellular crescent. Masson trichrome Gx250.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2070660-rId15.jpeg?20250522021037" />
   </fig>
   <fig id="fig3" position="float">
    <label>Figure 3</label>
    <caption>
     <title>Figure 3. IgA deposits on mesangium.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2070660-rId16.jpeg?20250522021037" />
   </fig>
   <p>The patient received 3 intravenous pulses of methylprednisolone at 1 g/1.73m<sup>2</sup> every 48 hr for one week combined with oral prednisone at 2 mg/kg/day and oral Azathioprine at 2 mg/kg/day for 3 months. Upon admission, he also received supportive treatment. After two weeks of oral prednisone and azathioprine, there was regression of extrarenal symptoms and gradual restoration of renal function without residual proteinuria. The patient’s renal outcome remained favorable after six months of follow-up, as shown in <xref ref-type="fig" rid="fig4">
     Figure 4
    </xref>.</p>
   <fig id="fig4" position="float">
    <label>Figure 4</label>
    <caption>
     <title>Figure 4. Creatinine and GFR evolution on corticosteroids + AZA treatment.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2070660-rId17.jpeg?20250522021037" />
   </fig>
  </sec><sec id="s3">
   <title>3. Discussion</title>
   <p>IgA vasculitis is the wide form of systemic vasculitis seen in children <xref ref-type="bibr" rid="scirp.142718-5">
     [5]
    </xref>. It can be encountered in all age groups but in 90% of cases, it occurs between 3 and 15 years of age, with a peak incidence between 4 and 6 years of age <xref ref-type="bibr" rid="scirp.142718-7">
     [7]
    </xref>. A slight male predominance is also described <xref ref-type="bibr" rid="scirp.142718-2">
     [2]
    </xref> <xref ref-type="bibr" rid="scirp.142718-8">
     [8]
    </xref>. IgA vasculitis affects all ethnicities but is rare in African Americans <xref ref-type="bibr" rid="scirp.142718-6">
     [6]
    </xref>. As Hamani et al. point out in their study, our patient was also of African descent <xref ref-type="bibr" rid="scirp.142718-9">
     [9]
    </xref>. Thus, although rare in black ethnicities, this highlights the genetic and geographic variability of IgA vasculitis <xref ref-type="bibr" rid="scirp.142718-10">
     [10]
    </xref>.</p>
   <p>Although cause-effect relationship of IgA vasculitis is difficult to establish, in 40% to 50% of cases, upper respiratory tract infections (URTIs) precede the onset of the disease <xref ref-type="bibr" rid="scirp.142718-6">
     [6]
    </xref> <xref ref-type="bibr" rid="scirp.142718-7">
     [7]
    </xref> <xref ref-type="bibr" rid="scirp.142718-11">
     [11]
    </xref>. Our patient reported recurrent pharyngitis thus suggesting a potential infectious trigger. He also reported generalised pruritic macular rashes. In our setting, this usually suggests diagnoses such as chickenpox, scabies and urticaria, which are much more frequent thus delaying early recognition of IgAV. In more than 95% of cases, the rash is an early sign of IgA vasculitis in children <xref ref-type="bibr" rid="scirp.142718-5">
     [5]
    </xref> <xref ref-type="bibr" rid="scirp.142718-9">
     [9]
    </xref> <xref ref-type="bibr" rid="scirp.142718-12">
     [12]
    </xref> <xref ref-type="bibr" rid="scirp.142718-13">
     [13]
    </xref>. The characteristic rash is a palpable no thrombocytopenic purpura that progresses from erythema to papules and then to palpable non blanching purpura <xref ref-type="bibr" rid="scirp.142718-1">
     [1]
    </xref> <xref ref-type="bibr" rid="scirp.142718-5">
     [5]
    </xref>. This may vary among patients. Atypical skin lesions may appear to healthcare personnel outside of flare-ups, contributing to IgAV misdiagnosis and requiring biopsy whenever possible <xref ref-type="bibr" rid="scirp.142718-4">
     [4]
    </xref>. In this case, skin biopsy was not available.</p>
   <p>The diagnosis of IgA vasculitis is primarily clinical. Besides the rash, other extra renal manifestations of IgAV in this case included abdominal and joint pain. These findings are similar to the study by Maha Oudrhiri et al. in Morocco who found joint and gastrointestinal manifestations in 56.5% and 65.5.8% of cases, respectively <xref ref-type="bibr" rid="scirp.142718-14">
     [14]
    </xref>. Sylvia Gomez et al. also reported gastrointestinal and joints involvement in 54 % and 82% of cases, respectively <xref ref-type="bibr" rid="scirp.142718-15">
     [15]
    </xref>. Gastrointestinal manifestations (GI) are present in 50% - 80% of patients with IgAV presenting primarily as diffuse abdominal pain <xref ref-type="bibr" rid="scirp.142718-11">
     [11]
    </xref>. In the presence of severe abdominal pain, it is mandatory to exclude an acute surgical abdomen. Abdominal ultrasound of our patient was normal, while esophagogastroduodenoscopy showed non erosive congestive pangastritis. The spectrum of endoscopic findings is based on the severity of the vasculitis <xref ref-type="bibr" rid="scirp.142718-16">
     [16]
    </xref>. Usually, irregular, ulcerative nodular lesions or hematoma-like protuberances are characteristic of IgA vasculitis in the duodenum <xref ref-type="bibr" rid="scirp.142718-16">
     [16]
    </xref>. Joint involvement in IgA vasculitis consists of a transient non migratory symmetrical polyarthralgia affecting mainly the large joints (especially the knees and ankles) <xref ref-type="bibr" rid="scirp.142718-5">
     [5]
    </xref> <xref ref-type="bibr" rid="scirp.142718-16">
     [16]
    </xref>.</p>
   <p>Even at this stage of clinical presentation, the diagnosis of IgA vasculitis remains challenging in our setting, considered rare, particularly in the presence of an atypical skin rash associated with abdominal and joint pain. It is therefore necessary for our health care practitioners, especially those in primary care, to include IgA vasculitis among their differential diagnoses in the presence of cutaneous, joint, and digestive manifestations in a child.</p>
   <p>This case also highlighted renal involvement of IgA vasculitis. Patient presented with a nephritic syndrome combining macroscopic hematuria, edema and grade 2 hypertension. Moderate glomerular proteinuria was also reported. Given the clinical course of this patient, it is legitimate to first consider post infectious glomerulonephritis which is much more common in our context. Therefore, laboratory investigations should search as much as possible post infectious causes of glomerulonephritis. In this clinical case, the infectious screening was negative and complement C3 and CH50 assays were normal. In the course of multiple organ symptoms and dysfunction, lupus nephritis can also be considered as a differential diagnosis and screened for. Anti-native DNA antibodies were negative in this case.</p>
   <p>Manifestations IgA vascular nephritis are variable. They range from hematuria and or proteinuria to chronic renal failure including nephritic and nephrotic syndrome <xref ref-type="bibr" rid="scirp.142718-17">
     [17]
    </xref>. In case of impaired estimated glomerular filtration rate (eGFR), persistent proteinuria, nephrotic or nephritic syndrome, renal biopsy is mandatory <xref ref-type="bibr" rid="scirp.142718-1">
     [1]
    </xref> <xref ref-type="bibr" rid="scirp.142718-2">
     [2]
    </xref> <xref ref-type="bibr" rid="scirp.142718-9">
     [9]
    </xref> <xref ref-type="bibr" rid="scirp.142718-10">
     [10]
    </xref>. Our patient had an altered eGFR of 30 ml/min/1.73m<sup>2</sup> (Schwartz), corresponding to Stage 3 acute renal failure according to the KDIGO classification.</p>
   <p>The performed renal biopsy reported morphological changes, immune deposits of IgA and C3 and identified severe crescentic glomerulonephritis with 95% glomerular involvement corresponding to ISKDC grade V <xref ref-type="bibr" rid="scirp.142718-18">
     [18]
    </xref>. This finding is similar to that of Sarina Butzner et al. who reported 100% mesangial IgA deposits on renal biopsy of all patients <xref ref-type="bibr" rid="scirp.142718-19">
     [19]
    </xref>. The pathological hallmark of IgAVN is the deposition of IgA-containing immune complexes in the renal mesangium. The deposited immune complexes activate the alternative complement pathway (with C3 deposition) and recruit inflammatory cells causing glomerulonephritis <xref ref-type="bibr" rid="scirp.142718-6">
     [6]
    </xref>. Currently, the International Study of Kidney Disease in Children (ISKDC) classification is mainly used for the histological analysis of IgAVN <xref ref-type="bibr" rid="scirp.142718-4">
     [4]
    </xref>.</p>
   <p>To date, there are few prospective, randomized, controlled studies on the treatment of IgAVN and their results remain controversial <xref ref-type="bibr" rid="scirp.142718-12">
     [12]
    </xref> <xref ref-type="bibr" rid="scirp.142718-20">
     [20]
    </xref> <xref ref-type="bibr" rid="scirp.142718-21">
     [21]
    </xref>. Some studies highlight a potential beneficial impact of corticosteroids. Oral prednisolone and/or pulsed methylprednisolone should be used as early treatment in mild to moderate cases <xref ref-type="bibr" rid="scirp.142718-4">
     [4]
    </xref>. Severe forms, corticosteroid-dependent and corticosteroid-resistant forms of IgAVN may require immunosuppressive treatments, such as calcineurin inhibitors (CNIs), azathioprine (AZA), cyclophosphamide, mycophenolate (MMF), rituximab and plasmapheresis <xref ref-type="bibr" rid="scirp.142718-4">
     [4]
    </xref> <xref ref-type="bibr" rid="scirp.142718-20">
     [20]
    </xref> <xref ref-type="bibr" rid="scirp.142718-22">
     [22]
    </xref>. AZA was used in our patient in combination with oral prednisolone for 3 months.</p>
   <p>The clinical outcome was favorable, with complete recovery of renal function. AZA has been shown to be effective in combination with oral corticosteroids in severe forms of IgAVN. No formal guidelines are available regarding the duration of treatment. In many studies, no patient experienced adverse effects associated with AZA treatment <xref ref-type="bibr" rid="scirp.142718-12">
     [12]
    </xref>.</p>
  </sec><sec id="s4">
   <title>4. Conclusion</title>
   <p>We reported in a resource-limited country a case of IgA vasculitis nephritis in an adolescent successfully managed despite late diagnosis. The combination of corticosteroids and Azathioprine resulted in a complete recovery of renal function and of regression of extra renal symptoms. This case therefore encourages awareness of the diagnosis of IgA vasculitis nephritis in the presence of acute nephritic syndrome associated with extra renal signs in order to improve prompt management and obtain a favorable outcome.</p>
  </sec><sec id="s5">
   <title>Acknowledgements</title>
   <p>We would like to thank the pediatric nephrology department of Abass Ndao University Hospital headed by Professor Younoussa Keita, the general pediatrics team and the pathology department of Cheikh Anta Diop University.</p>
  </sec><sec id="s6">
   <title>Ethical Consideration</title>
   <p>Informed consent form and permission for publication were granted from the patient and their parents.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.142718-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Pillebout, E. and Sunderkötter, C. (2021) IgA Vasculitis. Seminars in Immunopathology, 43, 729-738. &gt;https://doi.org/10.1007/s00281-021-00874-9
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Parums, D.V. (2024) A Review of Iga Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future. Medical Science Monitor, 30, e943912. &gt;https://doi.org/10.12659/msm.943912
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Xu, L., Li, Y. and Wu, X. (2022) IgA Vasculitis Update: Epidemiology, Pathogenesis, and Biomarkers. Frontiers in Immunology, 13, Article 921864. &gt;https://doi.org/10.3389/fimmu.2022.921864
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ozen, S., Marks, S.D., Brogan, P., Groot, N., de Graeff, N., Avcin, T., et al. (2019) European Consensus-Based Recommendations for Diagnosis and Treatment of Immunoglobulin a Vasculitis—The SHARE Initiative. Rheumatology, 58, 1607-1616. &gt;https://doi.org/10.1093/rheumatology/kez041
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Leung, A.K.C. (2020) Henoch-Schönlein Purpura in Children: An Updated Review. Current Pediatric Reviews, 16, 265-276. &gt;https://doi.org/10.2174/18756336mta2lndyc2
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dyga, K. and Szczepańska, M. (2020) IgA Vasculitis with Nephritis in Children. Advances in Clinical and Experimental Medicine, 29, 513-519. &gt;https://doi.org/10.17219/acem/112566
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Reamy, B.V., Servey, J.T. and Williams, P.M. (2020) Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review. American Family Physician, 102, 229-233.
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Vasküliti, I., Purpurası, H.S., Pediatrik, O., Epidemiyolojik, H., Ve, K., Bulgularının, L., et al. (2024) Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients with IgA Vasculitis (Henoch-Schönlein Purpura). Türkiye Çocuk Hastalıkları Dergisi, 18, 111-116.
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Hamami, A., Babakhouya, A., El Ouali, A., Ghannam, A., Rkain, M. and Benajiba, N. (2021) P062 Vasculitis in Children: Epidemiological, Clinical and Para Clinical Profile in the Oriental Region of Morocco—About 33 Cases. Rheumatology, 60, keab722.054. &gt;https://doi.org/10.1093/rheumatology/keab722.054
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gardner-Medwin, J.M., Dolezalova, P., Cummins, C. and Southwood, T.R. (2002) Incidence of Henoch-Schonlein Purpura, Kawasaki Disease, and Rare Vasculitides in Children of Different Ethnic Origins. The Lancet, 360, 1197-1202. &gt;https://doi.org/10.1016/s0140-6736(02)11279-7
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Amatruda, M., Carucci, N.S., Chimenz, R. and Conti, G. (2023) Immunoglobulin a Vasculitis Nephritis: Current Understanding of Pathogenesis and Treatment. World Journal of Nephrology, 12, 82-92. &gt;https://doi.org/10.5527/wjn.v12.i4.82
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Stone, H.K., Mitsnefes, M., Dickinson, K., Burrows, E.K., Razzaghi, H., Luna, I.Y., et al. (2023) Clinical Course and Management of Children with Iga Vasculitis with Nephritis. Pediatric Nephrology, 38, 3721-3733. &gt;https://doi.org/10.1007/s00467-023-06023-8
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Marro, J., Williams, C., Pain, C.E. and Oni, L. (2023) A Case Series on Recurrent and Persisting IgA Vasculitis (Henoch Schonlein Purpura) in Children. Pediatric Rheumatology, 21, Article No. 85. &gt;https://doi.org/10.1186/s12969-023-00872-1
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Oudrhiri, M., Bentahila, A. and Chkirate, B. (2020) Purpura rhumatoide de l’enfant: À propos de 46 cas. PAMJ Clinical Medicine, 2, Article 149. &gt;https://doi.org/10.11604/pamj-cm.2020.2.149.21147
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gómez, S., Pérez, M., et al. (2020) Henoch-Schonlein Purpura in Pediatrics: Ten Years of Experience at a Moderate Risk Office of a General Hospital. Archivos Argentinos de Pediatria, 118, 31-37.
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Jelusic, M., Sestan, M., Giani, T. and Cimaz, R. (2022) New Insights and Challenges Associated with IgA Vasculitis and Iga Vasculitis with Nephritis—Is It Time to Change the Paradigm of the Most Common Systemic Vasculitis in Childhood? Frontiers in Pediatrics, 10, Article 853724. &gt;https://doi.org/10.3389/fped.2022.853724
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Williams, C.E.C., Lamond, M., Marro, J., Chetwynd, A.J. and Oni, L. (2023) A Narrative Review of Potential Drug Treatments for Nephritis in Children with Iga Vasculitis (HSP). Clinical Rheumatology, 42, 3189-3200. &gt;https://doi.org/10.1007/s10067-023-06781-8
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Jelusic, M., Sestan, M., Cimaz, R. and Ozen, S. (2019) Different Histological Classifications for Henoch-Schönlein Purpura Nephritis: Which One Should Be Used? Pediatric Rheumatology, 17, Article No. 10. &gt;https://doi.org/10.1186/s12969-019-0311-z
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Butzer, S., Hennies, I., Gimpel, C., Gellermann, J., Schalk, G., König, S., et al. (2022) Early Clinical Course of Biopsy-Proven IgA Vasculitis Nephritis. BMC Pediatrics, 22, Article No. 570. &gt;https://doi.org/10.1186/s12887-022-03611-9
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Delbet, J., Parmentier, C., Herbez Rea, C., Mouche, A. and Ulinski, T. (2021) Management of IgA Vasculitis with Nephritis. Pediatric Drugs, 23, 425-435. &gt;https://doi.org/10.1007/s40272-021-00464-0
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Namgoong, M. (2020) Management of IgA Vasculitis Nephritis (Henoch-Schonlein Purpura Nephritis) in Children. Childhood Kidney Diseases, 24, 1-13. &gt;https://doi.org/10.3339/jkspn.2020.24.1.1
    </mixed-citation>
   </ref>
   <ref id="scirp.142718-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rohner, K., Marlais, M., Ahn, Y.H., Ali, A., Alsharief, A., Novak, A.B., et al. (2024) Outcome of Immunosuppression in Children with Iga Vasculitis-Related Nephritis. Nephrology Dialysis Transplantation, 39, 1299-1309. &gt;https://doi.org/10.1093/ndt/gfae009
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>